✦ LIBER ✦

Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data

✍ Scribed by M. Molimard; R. Buhl; R. Niven; V. Le Gros; A. Thielen; J. Thirlwell; R. Maykut; G. Peachey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

European Real-Life Experience Of Omalizu

✍ Molimard, M.; Niven, R.; Buhl, R.; Le Gros, V.; Thielen, A.; Thirlwell, J.; Pana 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Reductions In Oral Corticosteroid Use In

✍ Braunstahl, G.; Maykut, R.; Figliomeni, M.; Chen, C.; Peachey, G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Omalizumab in patients with severe persi

✍ S. Korn; A. Thielen; S. Seyfried; C. Taube; O. Kornmann; R. Buhl 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 213 KB

“Real-life” effectiveness of omalizumab

✍ G. Brusselle; A. Michils; R. Louis; L. Dupont; B. Van de Maele; A. Delobbe; C. P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 446 KB

Addition of Omalizumab Improved Function

✍ MASSANARI, M; SACCO, P; KIANIFARD, F; MAYKUT, R; ZELDIN, R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PRS21 COST-EFFECTIVENESS ANALYSIS OF XOL

✍ P Lecomte; CS Lee; FE Van Nooten; CL Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB